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Abstract. In this work we introduce the modeling of atrioventricu-
lar valve regurgitation in a spatially reduced order biomechanical heart
model. The model can be fast calibrated using non-invasive data of car-
diac magnetic resonance imaging and provides an objective measure of
contractile properties of the myocardium in the volume overloaded ven-
tricle, for which the real systolic function may be masked by the signifi-
cant level of the atrioventricular valve regurgitation. After demonstrating
such diagnostic capabilities, we show the potential of modeling to address
some clinical questions concerning possible therapeutic interventions for
specific patients. The fast running of the model allows targeting specific
questions of referring clinicians in a clinically acceptable time.
1 Introduction
Mitral or tricuspid regurgitation (MR, TR) also named mitral (tricuspid) valve
insufficiency or incompetent mitral (tricuspid) valve, is a condition in which the
atrioventricular (AV) valve allows backward flow (regurgitation) during systole
due to anatomical or functional defects. The AV valve regurgitation (AV-R)
is typically quantified by imaging techniques – echocardiography or magnetic
resonance imaging (MRI) – with classification into mild (regurgitation fraction
RF being below 30%, and regurgitation volume RVol< 30 ml), moderate (RF 30–
40% and RVol 30–45 ml), moderate-to-severe (RF 40–50%, RVol 45–60 ml) and
severe (RF above 50% or RVol above 60 ml). The ventricular volume overload
due to a moderate or severe AV valve insufficiency makes the assessment of
the true systolic function of ventricle rather difficult. The indicators practically
considered are the ventricular ejection fraction (EF), ventricular end-diastolic
volume (EDV) indexed to body surface area (iEDV) representing the level of
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ventricular dilatation, the percentage of RF, the regurgitation volume RVol and
the morphology of the leaking valve. Putting all these available data into a
clear clinical picture is not obvious and is one of the potentials of biomechanical
modeling.
Capturing the anatomy of valve leaflets coupled with a realistic 3D heart
model is mathematically extremely challenging and computationally intensive
[1], with a limited potential to be used at bedside. The role of such detailed
models would rather be in testing new valve implants, and the intensive com-
putations would be run in the prosthetic valve development. Our goal in this
paper is to present a relatively easy approach of incorporating the AV-R into a
biomechanical heart model with the capability to provide a fast quantification
of the actual contractile property of the ventricle, which would allow to objec-
tively assess the level of overload the patient’s heart is facing. The abnormal
contractility might play a very significant role in the mismatch between the clin-
ical assessment of a valve insufficiency and the actual outcome of a therapeutic
intervention on the valve [7] – a phenomenon not fully understood to date. We
aim at providing the clinical information in a relatively short time period, typi-
cally within hours – the time scale compatible with data analysis and reporting
for an MRI exam of heart disease patients – so that the added indicators could
be directly taken into consideration in clinical conclusions. Secondly, once the
model is set up using patient-specific data, it can be used to predict the effect
of possible valve repair or other therapeutic interventions – an information of
invaluable importance prior to deciding about the type of therapy.
The valve insufficiency has already been introduced in the cardiac model-
ing community as for instance for the pulmonary valve. In [6] a 3D mechanical
heart model was constrained by external forces from processed image data to
allow regurgitation flows. The model was used to estimate the constitutive prop-
erties of myocardium and a possible outcome of a complete valve repair was
predicted. In our case, the global mechanical model – including the component
of AV-valve insufficiency – that we are proposing allows to obtain more compre-
hensive predictions. Examples thereof include the investigation of the effect of a
partial improvement by invasive or non-invasive techniques – as is often the case
in correcting the AV valve insufficiency – or modifications of the physiological
properties of the cardiovascular system by a number of interventions, pharmaco-
logical or others. We will exemplify this variety of predictions with two clinical
cases and several associated treatment scenarios.
2 Methods
2.1 Clinical data
Two AV-R patients and one healthy control were analyzed in this pilot study.
The data used were the non-invasively acquired magnetic resonance imaging
data (MRI), together with peripheral pressure cuff measurement. MRI data con-
tained cine images in short axis (the stack covering whole ventricles and part of
the atria) and stacks of long axis orientations (typically 5–9 slices for 2-, 3- and
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4-chamber views) in order to well visualize the AV-valve defect in several orien-
tations throughout the cycle, and phase contrast images of flow though aortic
and pulmonary valves (the outflows of the ventricles).
The first patient has a moderate-to-severe MR with RF of 36% and RVol
45 ml, see Table 1. MR was caused by an anatomical defect in the posterior
valve leaflet leading to MR throughout the systole, which can be appreciated
in the top line of Fig. 1. The second patient is a TR patient with dilated RV –
which is connected to the systemic circulation and has outflow to the aorta (the
so-called systemic RV) – and in addition has a complete atrioventricular block
(i.e. the atria and ventricles beat independently with a very low ventricular rate
of ∼40 bpm). The defect in the tricuspid valve is central and disappears when
the RV volume falls below 200 ml (due to a decrease in size of the tricuspid
valve ring), as assessed from the detailed short and long axis cine MRI stacks
(see bottom line in Fig. 1).
Patient Age EDV iEDV EF RF RVol type of
# (years) (ml) (ml/m2) (%) (%) (ml) defect
Healthy control 30 130 70 55 0 0 N/A
1 17 246 119 59 36 45 MR
2 17 308 169 55 26 43 TR
Table 1. Patients’ information obtained during cardiac MRI exam.
While for the first patient mitral valve surgery might be indicated, the clin-
icians’ main question about the second patient is whether or not to implant a
pacemaker / CRT to correct the AV-block, as increasing the heart rate might
lead to a reduction of TR. In the sequel we will address these clinical questions
with the help of a biomechanical heart model.
2.2 Biomechanical heart model
The biomechanical model of heart function used in this work was detailed in
[2]. It is a reduced-order (0D) model, in which the ventricle of concern is rep-
resented by a sphere with the inner radius R and wall thickness d adjusted
according to the patient’s image data. The model contains anisotropic mechan-
ics with Holzapfel-Ogden-type hyperelastic potential in the passive component
and chemically controlled model of actin-myosin interaction for the active part.
The constitutive behavior is taken as transverse isotropic with respect to the
fiber direction, and the fibers are assumed to be isotropically distributed in the
orthoradial plane through the wall thickness. Consequently, the resulting overall
behavior is different in the radial vs. orthoradial directions, as detailed in [2].
The circulation system is represented by a 2-stage Windkessel model (see Fig.
2). The phases of the cardiac cycle and opening / closure of valves are handled
via a diode system as is described in [9]. In particular the AV-R is incorporated
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Fig. 1. Top: Mitral valve defect in Patient 1 with holosystolic regurgitant flow through
the defect (the opening at end-systole is marked by arrows). Bottom: Tricuspid valve
defect in Patient 2 present during early systole (left) and closing up during late systole
(right).
Vvia a two-direction diode which is controlled by the phase of cardiac cycle. Under
physiological conditions, the value of the AV valve conductance is set to a high
value Kopen when the valve is open with the resulting atrium-to-ventricle flow
being given by Kopen · (Pat − PV ), with Pat and PV standing for the atrial and
ventricle pressures. During the closure of the valve the conductance is set to a
very low value Kclose as a penalty for the negligible flow Kclose · (PV − Pat). By
increasing the coefficient Kclose the AV-R can be introduced and tuned to the
observed level of RF.
The complete heart-circulation model – i.e. the 0D cavity with the connected
Windkessel model – is calibrated sequentially. The order for calibrating each
component is given by the available data so that the calibrated part of a given
module is carried further into a more complete model. First, the geometry is ad-
justed according to the data (reference volume and wall thickness of the ventricle
[5]). Taking the advantage of having the measured flows leaving the ventricles
at hand, the parameters of Windkessel model (representing the circulation, we
recall Fig. 2) are tuned by directly imposing the measured flow at the inlet and
using the peak and minimal arterial pressure taken by cuff measurement. The
passive parameters are adjusted according to the clinically predicted atrial pres-
sure. Finally, the active contractility is calibrated in order to obtain the peak
aortic flow velocity as in the data. The main mechanical parameters of the model
are summarized in Table 2.
Concerning the calibration of the AV valve insufficiency, we kept the coeffi-
cient Kclose constant for Patient 1, while for Patient 2 we made Kclose linearly
dependent on the volume of ventricle VV with no regurgitation for the ventric-
ular volume below the limit observed in the image data (V competentV = 200ml).
In detail,
Kclose =
{
αKincompetent valveclose + (1− α)Kcompetentclose when VV > V competentV
Kcompetentclose when VV ≤ V competentV ,
with linear interpolation factor α =
VV −V competentV
V EDV
V
−V competent
V
.
Patient Relat. passive Contractility Periph. resistance Periph. capacitance
# stiffness (kPa) (Pa s/m3) (m3/Pa)
Healthy control 1.0 60 1.55 · 108 1.1 · 10−8
1 1.13 92 1.1 · 108 1.5 · 10−8
2 1.0 125 108 2.2 · 10−8
Table 2. Main parameters of the model.
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Fig. 2. Schematics of the model including the dual-direction diode for the AV-valve.
3 Results
Fig. 3 shows the level of accuracy obtained by our model representing the data
in the measured key indicators. Table 1 summarizes data for the subjects in the
study as obtained by a routine clinical analysis of the MR exam, together with
the estimated myocardial contractility value. Note that the ventricular size of
Patient 1 is moderately increased (normal iEDV being below 100 ml/m2) and
the ventricle of Patient 2 is severely dilated. According to the standard clinical
assessment of systolic function, both patients fall into normal range (EF≥ 55%).
When comparing the level of ventricular contractility as estimated by the model
(see Table 2), both patients have the contractility above the normal population
(60–70 kPa, as exemplified by our healthy control case). The level of contractility
in Patient 1 is mildly increased, and the contractility value of Patient 2 is already
at moderately elevated inotropic level, even though the patient is at rest.
To better appreciate the patients’ heart function, we plot in Fig. 4 the car-
diac output as a function of the preload. We can see that in both cases the cur-
rent working point is on a rather flat part of these “Starling curves”, relatively
independent of the current preload. Both patients have no signs of damaged my-
ocardium (in particular, no post-infarction scarring was present in gadolinium
late-enhancement MRI), and we would therefore expect the level of contractility
to be able to increase to a level of 180 kPa – in our experience the level ob-
tained by using a moderate dose of inotropic drug in stress studies performed
in clinically indicated cases [11]. The red cardiac output curve in Fig. 4 shows
a prediction of such an inotropic effect. While the cardiac output of Patient 1
could significantly increase, the predicted cardiac output increase for Patient 2
is rather limited. This plot suggests that Patient 2 is more urgent to treat, as
the contractile reserve of the patient’s heart (which would be available to com-
pensate for instance an acute destabilization of the patient’s state) is limited,
even though the level of RF is significantly less than for Patient 1.
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Fig. 3. Indicators of the calibrated models compared with the available data for Pa-
tient 1 (top row) and Patient 2 (bottom row).
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Fig. 4. Heart function presented as patient-specific cardiac output-vs-preload curves
at the current physiological state (black solid line), and as predicted if the contractility
was increased to a high level of 180kPa (red line).
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Finally, Figs. 5 and 6 demonstrate the effect of therapies in question for the
two patients. By correcting the mitral valve in Patient 1, while the inotropic level
is kept at the same level, the model predicts that the heart will be working on
smaller volumes (see blue curves in Fig. 5). This could be beneficial for the level of
tissue stress and may induce a reverse remodeling of the dilated heart and bring
the heart volumes from moderate dilatation to normal size. Alternatively, to
reach the cardiac output as at baseline (5.3 l/min), the myocardial contractility
could decrease by 15% – which would have positive effects on the heart energy
requests.
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Fig. 5. Predicted effect of mitral valve repair in Patient 1: Patient’s heart could work
on the same level of contractility but on a lower preload (blue plot), or on a lower
contractility level (red), assuming the repair would practically completely resolve the
MR.
For Patient 2, the model predicts a significant reduction of the regurgitation
fraction when increasing the heart rate from 40 bpm to the normal value of
60 bpm after implanting a pacemaker, thanks to a reduction of the ventricular
volume (see blue curves in Fig. 6). Even by reducing the the contractility by 10%
represented by red curves – which would definitely be of benefit for the patient,
recall Fig. 4 – RF would still be around 14% (considered as only a trivial-mild
level of TR).
4 Discussion and future work
A detailed visualization of the AV valve by a high number of cine slices in
superior temporal resolution was key to adjust the AV-valve conductance in the
central-TR defect, which was closing up for the smaller ventricular volumes.
Although acquiring the additional ∼20 slices in long axis orientations represents
extra 10–20 minutes of scanning, this extra time is worthy for a better visual
analysis and also for an increased level of model personalization in this patient.
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Fig. 6. Predicted effect of pacing on the tricuspid valve regurgitation fraction in Pa-
tient 2.
Measurements of the AV flow by MRI are not routinely performed because of
a limited reproducibility and accuracy. Our experience from the presented pilot
study, however, shows that even a solely qualitative profile of the regurgitation
jet (as shown for Patient 1 in Fig. 1, obtained actually from the flow image
targeted on the through-aortic valve flow) would facilitate the process of setting
up the model correctly, and will be included for future patients. Our study was
completely non-invasive with data acquired during a routine congenital heart
disease MRI exam. The obtained pressure was just a brachial cuff measurement
and we tuned our model (i.e. the Winkessel resistances and capacitances Rp, Rd,
Cp and Cd, see Fig. 2) to the corresponding two measured pressure points (min-
imum diastolic and maximum systolic) as if these points were present directly
in the proximal aorta. We are aware of the difference between the central and
peripheral pressure measurements, but the error in the range of 5–10 mmHg is
acceptable for our purpose (as a comparison, in the cohort of patients followed,
10–20% error in RF does not necessarily mean any difference in a standardized
therapy). We do however plan to perform a sensitivity analysis with respect to
the measured peripheral pressure for a group of patients with available central
aortic pressure. The uncertainty of all parameters could be studied independently
for each component of the model (Winkessel, passive and active properties), and
remains to be done in future.
Our model suggests that correcting the MR in Patient 1 would be beneficial,
and also directly gives some complementary therapeutic guides, e.g. the effect
of decreasing contractility, or volume of circulating fluid which is adjusted by
intrinsic physiological mechanisms of “pressure driven diuresis / natriuresis” [4]
possibly supported by antidiuretic drugs. In this work, we have not dealt with
the important effect of coupling the cardiac function with venous return as in [3,
8], even though this would allow predicting using the antidiuretics, and we plan
to extend our study also in this respect.
Our predictions for Patient 2 suggest a beneficial effect of pacing. We have to
point out, however, that our model only captures the immediate effects and does
Xnot include possible negative effects caused by artificially fast rate. The validity
of prediction of immediate effect of pacing, namely the changes of end-diastolic
and stroke volume indicators, is a subject in our current clinical study in which
the patients with MR conditional CRT devices are included. Instead of MRI,
the echocardiography data processed into 0D signals of ventricular volumes and
aortic flows could be used with the advantage of a possible validation on a much
larger cohort by avoiding the contraindication of MRI in the majority of CRT
patients.
Patient 2 has a congenital disease called congenitally-corrected transposition
of great arteries (ccTGA), which is a very rare pathology. However, we believe
that it is a group of patients who might extremely benefit from modeling. First,
reduced order models – as the one used in the present work – can allow a quick
assessment of the contractile properties of the remodeled systemic right ven-
tricle – typically associated with some degree of TR – and predict the effect
of possible pacing, as the AV block is commonly present in ccTGA. Secondly,
the inter- and intra-ventricular delays (also common in ccTGA) may be directly
treated by using a biventricular pacing (CRT) with a possibility of employing
more detailed 3D models, which are able to capture the propagation of electrical
activation throughout the myocardial tissue, with the aim to optimize the CRT
[10]. Modeling can change the management of these patients since their early
ages.
All the simulations performed in the present work rely on the assumptions of
reduced order (0D) mechanical modeling [2] and therefore possess some limita-
tions compared to 3D modeling. The 0D approach cannot rigorously capture the
inhomogenities of material parameters, such as alterations of passive myocardial
stiffness and active contractility in the infarcted heart. The effective spatial av-
eraging of these parameters may lead to errors, e.g. false negativity if trying to
discover an increased level of contractility at rest. Similarly, the propagation of
electrical activation – often pathological in the AV-R patients with dilated ven-
tricles – can be taken into account only by imposing the duration of propagation
of depolarization wave according to the measured QRS duration in patients’
ECGs. Local branch / partial blocks therefore cannot be directly included. We
expect that out of these two limitations, the former one has a larger impact, and
a fully 3D approach should therefore be considered in the infarcted hearts.
The fast run of 0D simulations, however, allows investigations of a number of
virtual scenarios in a very short time. Indeed, one of the objectives in carrying out
this work was to allow medical doctors to directly perform such simulations and
hypothetical scenarios by themselves, in parallel with reporting on patients’ MRI
scans. Our experience from the presented work and other projects [8] suggests
that the complexity of the model is such that this aim is realistic, indeed.
5 Conclusion
This paper shows a promising pathway in employing simplified models address-
ing the clinical questions for a given patient to extend the capabilities of imaging
XI
techniques. Although the pathology in question is related to the valves, the con-
sequences on the myocardium itself are what really matters. Including modeling
in clinical decision making has the potential to push further the understand-
ing of the state of patients’ hearts and predicting the effect of therapeutical
interventions.
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